107 results on '"Schlitzer, Martin"'
Search Results
2. Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects
3. Derivatives of biarylalkyl carboxylic acid induce pleiotropic phenotypes in adult Schistosoma mansoni in vitro
4. The antimalarial pipeline – An update
5. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites
6. From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity.
7. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone
8. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides
9. Synthesis and antischistosomal activity of linker‐ and thiophene‐modified biaryl alkyl carboxylic acid derivatives.
10. Non-thiol farnesyltransferase inhibitors: n-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
11. Non-Thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones
12. Non-thiol farnesyltransferase inhibitors: structure–activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors
13. Non-thiol Farnesyltransferase Inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic Acid Amides
14. Discovery of a novel lead structure for anti-malarials
15. Design, synthesis and early structure–activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate
16. Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: structural requirements of the central moiety for farnesyltransferase inhibitory activity
17. Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors
18. Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors
19. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents
20. Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti‐schistosomal Activity.
21. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
22. FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicity.
23. Biarylalkyl Carboxylic Acid Derivatives as Novel Antischistosomal Agents.
24. N-Acyl Derivatives of 4-Phenoxyaniline as Neuroprotective Agents.
25. Novel Type II Fatty Acid Biosynthesis (FAS II) Inhibitors as Multistage Antimalarial Agents.
26. Wirkstoffe gegen Mycobacterium tuberculosis in klinischer Anwendung.
27. M2-Inhibitoren und Neuraminidase-Inhibitoren. Wirkstoffe gegen Grippe.
28. Feeding the Antimalarial Pipeline.
29. Wirkstoffe gegen Wurm- und Protozoenerkrankungen und das Virustatikum Ribavirin. Medizinische Chemie einiger 'Exoten'.
30. Wirkstoffe zur Behandlung der Afrikanischen Schlafkrankheit. Im letzten Jahrhundert entwickelt.
31. Wirkstoffe gegen Malaria: Was ist in der Pipeline? Wenig Neues im Kampf gegen die Malaria.
32. Medizinische Chemie der Wirkstoffe gegen Malaria. Wirk- und Resistenzmechanismen.
33. Structure-Based Optimization of Aldose Reductase Inhibitors Originating from Virtual Screening.
34. First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic Compounds.
35. Development of Benzophenone-Based Farnesyltransferase Inhibitors as Novel Antimalarials.
36. Studies Addressing the Importance of Charge in the Binding of Fosmidomycin-Like Molecules to Deoxyxylulosephosphate Reductoisomerase.
37. Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development.
38. Non-Thiol Farnesyltransferase Inhibitors: Evaluation of Different AA(X)-Peptidomimetic Substructures in Combination with Arylic Cysteine Replacements.
39. Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements.
40. Non-Thiol Farnesyltransferase Inhibitors: Structure-Activity Relationships of Aralkylsubsituted Benzophenones.
41. Different Amino Acid Replacements in CAAX-Tetrapeptide Based Peptidomimetic Farnesyltransferase Inhibitors.
42. Iminium carbonic acid derivative salts. IX.
43. Iminium carbonic acid derivative salts. X.
44. 3-(2,5-Dioxopyrrolidin-1-yl), 3-(2,6-dioxopiperidin-1-yl), and 3-(1,3-dioxoisoindolin-2-yl)rhodanines. a novel type of rhodanine derivatives.
45. Synthesis of 3-aminorhodanine derivatives as aldose reductase inhibitors.
46. Hemmstoffe der Farnesyltransferase: Ein neuer Ansatz zur Entwicklung potentieller Krebstherapeutika.
47. Iminiumkohlensäurederivat-Salze, 7. Mitt. Teil I: Elektrophile Reaktionen von 2-Methylthio-5,6-dihydro-4 H1,3-thiaziniumiodiden, 2-Methylthio-4,5-dihydrothiazoliumiodiden und 2-Methylthio-5-methylthiazoliumiodiden mit N-Nucleophilen.
48. Nitrosierungen an Hydrazinderivaten, 10. Mitt.: Oxidationen an Thiourethanen, 11. Mitt.: Reaktionen von 3-Aminorhodaninen unter nitrosierenden Bedingungen.
49. Regioselektive Kondensationen sowie N-Acylierungen an 3-Aminorhodaninen.
50. Synthese und biologische Wirksamkeit neuer N, N-disubstituierter 5-Alkyliden- bzw. 5-Aralkyliden-3-aminorhodanine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.